Document is current
Any future updates will be listed below
-
Authors
Narayanan, Harini https://orcid.org/0000-0003-4545-4885
Hinckley, Joshua A.
Barry, Rachel
Dang, Brendan
Wolffe, Lenna A. https://orcid.org/0009-0005-2492-6371
Atari, Adel
Tseng, Yuen-Yi
Love, J. Christopher https://orcid.org/0000-0003-0921-3144
-
Funding
Funding for this research was provided by:
MIT AltHost Research Consortium, SPARC grant from Broad Institute, Daniel I.C. Wang (1959) Faculty research innovation fund at MIT, Mazumdar-Shaw International Oncology fellowship
- License Information
-
More Information
Article History
Received: 9 December 2024
Accepted: 13 June 2025
First Online: 1 July 2025
Competing interests
: J.C.L. has interests in Amplifyer Bio, Sunflower Therapeutics PBC, Honeycomb Biotechnologies, OneCyte Biotechnologies, QuantumCyte, and Repligen. J.C.L.’s interests are reviewed and managed under MIT’s policies for potential conflicts of interest. The remaining authors declare no competing interests.
